CUMBERLAND PHARMACEUTICALS INC - 8-K Filing

Cumberland Pharmaceuticals reports Phase 2a ASSIST-SSc trial top-line results for oral ifetroban, demonstrating safety and tolerability in systemic sclerosis patients.

SEC EDGAR ·

Tickers: $CPIX

Read the full article at SEC EDGAR

More Regulatory news